The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 339:42-44 July 2, 1998 Number 1
NextNext

Sickle Cell Disease — New Treatments, New Questions

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Adams, R. J.
-PubMed Citation
The history of sickle cell disease shows how tortuous the road can be from the discovery of the mechanism of a disease to improvement in the care of affected patients. A series of extraordinary scientific achievements began in the 1940s: Pauling established sickle cell anemia as the first molecular disease, Ingram identified the critical amino acid substitution in the {beta}-globin chain, Perutz described the three-dimensional structure of hemoglobin, and Harris recognized the pathologic role of rigid intracellular polymers of hemoglobin S. Meanwhile, patients with sickle cell disease continued to suffer bouts of severe pain, disabling strokes, and fatal infections. Those . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.